معرفی
Claire Francesca Meehan is an Associate Professor in the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research focuses on motor control mechanisms, particularly in the context of neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS). She leads the Meehan Lab, which investigates neural plasticity, spinal cord function, and neuromuscular disorders using advanced neurophysiological techniques.
Dr. Meehan's primary research interests span several key areas in neuroscience:
- Mechanisms of motor neuron dysfunction in ALS
- Neural plasticity in spinal cord circuits
- Axon initial segment dynamics and function
- Cholinergic modulation of motor neurons
- Neuromuscular junction pathology
- Translational approaches to neuromuscular disorders
Her recent publications (2020-2025) demonstrate a strong focus on understanding the cellular and molecular mechanisms underlying ALS progression, particularly examining TDP-43 pathology, axon initial segment plasticity, and C-bouton alterations. Her work bridges basic neuroscience with clinical applications, using both rodent models and human patient data to identify potential therapeutic targets for neurodegenerative diseases. The research shows progressive investigation from molecular mechanisms to potential therapeutic interventions.
Dr. Meehan is actively involved in academic service, having contributed editorials on propriospinal neurons and their role in locomotion and spinal cord injury. Her research has been cited multiple times across various publications, indicating significant impact in the neuroscience community. She has also contributed to pain research through work on PDZ domain inhibitors for neuropathic pain treatment.
She leads the Meehan Lab, which appears to focus on motor control neuroscience with particular emphasis on spinal cord circuitry and neuromuscular function. The lab utilizes a range of techniques including neurophysiology, molecular biology, and animal models to investigate mechanisms of motor neuron disease and potential therapeutic interventions.
